Evaluating Effects of Curcumin in Moderate to Severe Asthmatics
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigator-initiated study is to evaluate the effects of oral curcumin
supplementation versus placebo in adult patients with moderate to severe asthma. Curcumin, a
derivative of turmeric, has been shown in animal models to inhibit the secretion of
pro-inflammatory cytokines and decrease airway constriction and hyperreactivity with only a
few observational studies available in humans with discordant results.